TLR4 gene silencer (Medistem)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameTLR4 gene silencer (Medistem)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionToll like receptor 4 antagonists

TargetsToll like receptor 4

Therapy Area/IndicationsReperfusion Injury

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMedistem Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMedistem Inc

Active IndicationsN/A

Inactive IndicationsReperfusion Injury

ATC CodeN/A